Pharmafile Logo
Pharmafocus logo
Advanced Search
Biogen image

Biogen shortens name and posts positive Alzheimer’s results

March 23, 2015
Sales and Marketing AD, Alzheimer's, BIIB037, Biogen, MS, Parkinson's, aducanumab, idec

Biogen Idec is to be known only as Biogen hence forth as the US biotech also reveals positive early results …

News
steve_cottrell3

Maetrics announces new president

March 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing maetrics, steve cottrell

Maetrics has confirmed that Steve Cottrell, previously its vice president of sales, will now assume the role of president at …

Appointment
Janssen image

J&J acquires Index Ventures-owned firm XO1

March 23, 2015
Sales and Marketing Index Ventures, Isis, J&J, JJ, Janssen, vectura, xo1

Johnson & Johnson’s pharma unit Janssen has acquired Index Ventures’ biopharma firm XO1 Limited that develops the promising anti-thrombin antibody …

News
Lilly image

Lilly and Hanmi enter immunological therapy pact

March 20, 2015
Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly

Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …

News
NHS image

Budget 2015: £1.25 billion boost for mental health services

March 20, 2015
Sales and Marketing Budget, Cameron, Miliband, NHS, Osborne, UK

Senior NHS figures have hit out at Chancellor George Osborne’s failure to lay out any specific plans concerning the future …

News
Breo image

GSK and Theravance see FDA nod for asthma indication

March 20, 2015
Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

News
michael_r_gallagher_actavis

Actavis gains new Allergan directors

March 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell

Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …

Appointment
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
Herceptin image

Breast cancer treatment market booming

March 19, 2015
Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb

The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …

News
Daiichi image

AstraZeneca and Daiichi team up for constipation drug

March 19, 2015
Sales and Marketing AstraZeneca, Daiichi, Movantik, constipation, naloxegol, oic

AstraZeneca and Daiichi Sankyo have signed a deal worth around $825 million to jointly commercialise constipation drug Movantik in the …

News
Sanofi image

Sanofi diabetes drug fails to show cardio disease benefit

March 19, 2015
Research and Development, Sales and Marketing ACS, Lixisenatide, Lyxumia, Sanofi, cardio, diabetes

A Phase IIIb study of Sanofi’s diabetes drug lixisenatide has shown it is no better or worse than a placebo …

News
Teva image

Teva and Ignyta shake hands in oncology deal

March 19, 2015
Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology

Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …

News
paul_wallace

MISSION hires chief business officer from Medivir

March 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medvir, mission, paul wallace

UK, Cambridge-based cancer biotech MISSION Therapeutics has appointed Dr Paul Wallace as its chief business officer. Having worked in business …

Appointment
Obama image

Pharma to profit from Obama reforms

March 18, 2015
Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance

President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …

News
Valeant image

Valeant sprints ahead of Endo to secure Salix

March 18, 2015
Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix

Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …

News
astrazeneca image

AstraZeneca buoyed by late-stage trial success

March 18, 2015
Sales and Marketing AstraZeneca, copd. asthma, formoterol fumarate, glycopyrronium, ptoo3, respiratory

AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …

News
Survey

The 2015 European Life Sciences Industry Survey on Customer Data

March 18, 2015

Dear Colleague, You are invited to take part in the 2015 European Life Sciences Industry Survey on Customer Data. Your …

Feature
GSK image

GSK premature babies drug starts late-stage trials

March 18, 2015
Sales and Marketing GSK, Retosiban, atosiban, babies, birth, oxytocin, premature

GlaxoSmithKline has initiated Phase III studies to evaluate the safety and efficacy of an investigational treatment for babies born prematurely. …

News
sharon_johnson_catalent

Catalent Pharma Solutions names new unit head

March 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing catalent pharma solutions, sharon johnson

UK pharma and healthcare products firm Catalent Pharma Solutions has picked its senior VP Sharon Johnson of the company’s quality …

Appointment

Baxter’s haemophilia drug performs

March 17, 2015
Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa

Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026